Pharmacological stress testing with technetium-99m single-photon emission computerized tomography imaging in the preoperative assessment of patients undergoing noncardiac surgery.
Pharmacological stress testing with Tc-99m sestamibi is being used extensively for the diagnosis of coronary disease. Although there are no randomized and prospective studies using this technique for preoperative evaluation of patients undergoing noncardiac surgery, there are several studies that indicate that it is equivalent to exercise perfusion imaging and can be used for evaluating the prognosis of patients with coronary artery disease (CAD). This review will discuss these studies.
Heller
G V
GV
Nuclear Cardiology Laboratory, Hartford Hospital, CT 06102-5037, USA.
Shehata
A R
AR
D003327:Coronary Disease / Q000000981:diagnostic imaging* / Q000209:etiology / Q000503:physiopathology; D015150:Echocardiography, Doppler; D004562:Electrocardiography; D005080:Exercise Test / Q000379:methods; D006801:Humans; D011300:Preoperative Care / Q000379:methods*; D019275:Radiopharmaceuticals; D013514:Surgical Procedures, Operative / Q000009:adverse effects*; D017256:Technetium Tc 99m Sestamibi; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*
D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi